TP53 and neoplasm: On the contrary, TP53 truncating mutation was presented in 72.7% well differentiated tumors vs. 20.0% in moderate differentiated tumors (P = 0.001) and 33.3% in poor differentiated tumors (P = 0.036), indicating TP53 missense mutation instead of truncating mutation was associated with poor tumor differentiation.